With the ODAC meeting just 1 week away, it looks like those on the sidelines are going to wait this out and see if the ODAC gives our drug a recommendation for approval. I thought there would be a build up but investors appear to be chicken hearted with this.
It's been a long ride, but we're on the cusp. Hopsira bet $17 million this would get approved.
1 week until the good news with the ODAC. Then, hopefully FDA approval in March. If that transpires according to plan, we're sliding on the ice with a Cuban stogie on our mouth and a glass of Jose Cuervo in our hand...(or insert your own personal favorite beverage)
I bought a little more yesterday, so I haven't lost the faith.
Good luck everybody.
CXS Price at posting:
85.5¢ Sentiment: Buy Disclosure: Held
